What is the dosage of Ensifentrine?
Ohtuvayre (Ensifentrine)-Ensefentine Inhalation Suspension is a drug used to treat chronic obstructive pulmonary disease (COPD). Its main function is to inhibit the inflammatory response and expand the airways through a dual mechanism, thereby effectively relieving the patient's respiratory symptoms. The method of use and dosage of this drug need to be adjusted according to the patient's specific condition and the advice of the doctor.
The recommended usage of exefantine is through aerosol inhalation. The specific dosage is 3 mg per time (one unit dose ampoule), twice a day, inhaled in the morning and evening. This usage has great advantages in ensuring that the drug can directly act on the patient's respiratory tract, thereby more effectively relieving airway inflammation and improving airway patency. Compared with oral drugs, atomized inhalation can deliver the drug directly into the lungs and exert its effect quickly. Therefore, this method of administration has better effects and higher efficacy for patients with respiratory diseases.

When using exefantine, patients need to use a standard jet nebulizer with a port for inhalation. This kind of atomizer can convert drugs into tiny mist particles and enter the respiratory tract through oral inhalation, ensuring that the drug can reach the lungs accurately and quickly to exert its effect. When using a nebulizer, patients need to follow correct operating procedures to ensure maximum inhalation effectiveness of the medication.
When using exefantine, patients should pay special attention to the following points: First, the cleaning of the nebulizer is crucial, because the residue in the nebulizer may affect the inhalation effect of the drug and may even cause infection. Patients should clean the nebulizer regularly and ensure that the medication reservoir is filled with sufficient medication before each use. Secondly, patients should undergo regular check-ups according to the doctor's instructions when using drugs to ensure the effectiveness of the drug and avoid overdose or side effects.
Reference materials:https://www.drugs.com/monograph/ensifentrine.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)